![]() |
![]() | ![]() |
| We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level. |
On Friday NEXM announed that phase 1 trials for female sexual dysfunction were encouraging and will proceed with phase 2 testing. Patent positions as well as Management and Board have impressive credentials. However, like most small research companies balance sheet looks thin. Will this company burn up its cash before major JV partner or break through? Looks interesting for speculative investment - comments please - come on you Purdue University boys!
| ||||||||||||
|
| Home | Hot | SubjectMarks | PeopleMarks | Keepers | Settings |
| Terms Of Use | Contact Us | Copyright/IP Policy | Privacy Policy | About Us | FAQ | Advertise on SI |
| © 2025 Knight Sac Media. Data provided by Twelve Data, Alpha Vantage, and CityFALCON News |